CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic Amyloidosis
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs such as CC-5013 and dexamethasone may be effective in treating primary
systemic amyloidosis.
PURPOSE: This phase II trial is studying CC-5013 to see how well it works with or without
dexamethasone in treating patients with primary systemic amyloidosis.